Brio Nutrition is a rapidly growing health and wellness CBD
brand, owned by 1606 Corp, and has recently secured a major
distribution deal with Cool Blue Distribution. As part of this
deal, Brio Nutrition is supplying its CBD products to some Cool
Blue's extensive network of over 800 stores. To keep up with the
demand generated by exciting new partnerships, Brio Nutrition has
announced that it has ordered $150,000 in new inventory
to accommodate demand, and a more substantial order in the
works.
The products have been well received by consumers, resulting in
a significant increase in sales for 1606 Corp. The success of the
Brio Nutrition products in the market is largely due to their
high-quality, innovative CBD formulations. Brio has excelled
through top tier branding and packaging. This has resulted in a
loyal customer base that continues to grow nationwide.
"The partnership with Cool Blue has been great, which gives us
access to their network which is why we have to place a new
inventory order. Our margins are great, so this is a big step for
Brio and for CBDW," said Greg Lambrecht, CEO 1606 Corp.
About 1606 Corp;
In April 2021, 1606 Corp. was spun off from Singlepoint Inc.
(OTCQB: SING).1606 has been able to add a variety of CBD products
under the Brio Nutrition line, and smokable hemp brands Truz and
CBD Singlz. The company intends to acquire Companies in the CBD,
including brands, distribution, retail outlets, and manufacturing.
1606 Corp. was awarded the ticker symbol CBDW in mid-January
2022.
Industry Information;
Rates of cannabidiol (CBD) usage in the United States are
projected to surge in 2023, according to industry With recent
studies suggesting as high as a 10% year-over-year (YoY) increase
in usage, Top CBD supplier predicts that 2023 will be a pivotal
year for the industry as the widespread adoption of CBD-infused
products is set to take place across the health and wellness,
beauty, and food and beverage industries. Data from 2022 provides
insight into the widespread nature of CBD-infused products. The
Center for Advancing Health (CFAH) reported that 26% of Americans
used CBD in 2022, and according to
ClevelandClinic.org, https://my.clevelandclinic.org/. It is also often
marketed toward individuals struggling with anxiety, depression,
quitting smoking, fitness recovery, and post-traumatic stress
disorder (PTSD).
Forward-Looking Statements
This press release contains statements that constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. These statements
appear in a number of places in this release and include all
statements that are not statements of historical fact regarding the
intent, belief, or current expectations of 1606 Corp (the
"Company"), its directors, or its officers with respect to, among
other things: (i) financing plans; (ii) trends affecting its
financial condition or results of operations; (iii) growth strategy
and operating strategy. The words "may," "would," "will," "expect,"
"estimate," "can," "believe," "potential" and similar expressions
and variations thereof are intended to identify forward-looking
statements. Investors are cautioned that any such forward-looking
statements are not guarantees of future performance and involve
risks and uncertainties, many of which are beyond the Company's
ability to control, and actual results may differ materially from
those projected in the forward-looking statements as a result of
various factors. You should not place undue reliance on
forward-looking statements since they involve known and unknown
risks, uncertainties, and other factors, which are, in some cases,
beyond the Company's control and which could, and likely will
materially affect actual results, levels of activity, performance,
or achievements. The Company assumes no obligation to publicly
update or revise these forward-looking statements for any reason,
or to update the reasons actual results could differ materially
from those anticipated in these forward-looking statements, even if
new information becomes available in the future. Important factors
that could cause actual results to differ materially from the
company's expectations include but are not limited to, those
factors that are disclosed under the heading "Risk Factors" and
elsewhere in documents filed by the company from time to time with
the United States Securities and Exchange Commission and other
regulatory authorities.
Company Websites;
www.CBD.Inc
www.brionutrition.com